Skip to content
10-Q

Quarterly Report

SCYNEXIS, Inc. SCYX

0000950170-25-072548

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 1, 2025 39.02M sh
Short Term Investments Q1 2025 · Mar 31, 2025 $33.67M
Short Term Investments Q1 2025 · Dec 31, 2024 $43.25M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $6.94M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $16.05M
Current Liabilities Q1 2025 · Mar 31, 2025 $8.96M
Current Liabilities Q1 2025 · Dec 31, 2024 $24.1M
Total Liabilities Q1 2025 · Mar 31, 2025 $17.38M
Total Liabilities Q1 2025 · Dec 31, 2024 $35.57M
Current Assets Q1 2025 · Mar 31, 2025 $52.22M
Current Assets Q1 2025 · Dec 31, 2024 $72.18M
Total Assets Q1 2025 · Mar 31, 2025 $67.92M
Total Assets Q1 2025 · Dec 31, 2024 $90.64M
Shares Diluted Q1 2025 · Mar 31, 2024 48.57M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$4.01M
Stockholders Equity Q1 2025 · Mar 31, 2024 $74.11M
Stockholders Equity Q1 2025 · Dec 31, 2023 $72.96M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.01
Eps Basic Q1 2025 · Mar 31, 2024 $0.01
Sga Expense Q1 2025 · Mar 31, 2024 $3.67M
Rd Expense Q1 2025 · Mar 31, 2024 $7.21M
Net Income Q1 2025 · Mar 31, 2024 $411K
Operating Income Q1 2025 · Mar 31, 2024 −$9.51M
Revenue Q1 2025 · Mar 31, 2024 $1.37M